Ad is loading...
JLVRX
Price
$22.71
Change
-$0.13 (-0.57%)
Updated
Nov 15 closing price
VIVIX
Price
$68.70
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
Ad is loading...

JLVRX vs VIVIX

Header iconJLVRX vs VIVIX Comparison
Open Charts JLVRX vs VIVIXBanner chart's image
JPMorgan Large Cap Value R5
Price$22.71
Change-$0.13 (-0.57%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.70
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
JLVRX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JLVRX vs. VIVIX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLVRX is a Buy and VIVIX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. JLVRX (5.11B). VIVIX pays higher dividends than JLVRX: VIVIX (2.37) vs JLVRX (1.61). JLVRX was incepted earlier than VIVIX: JLVRX (19 years) vs VIVIX (26 years). JLVRX is a more actively managed with annual turnover of: 143.00 vs. VIVIX (10.00). JLVRX has a lower initial minimum investment than VIVIX: JLVRX (0) vs VIVIX (5000000). JLVRX (26.55) and VIVIX (25.54) have marching annual gain over last year. JLVRX return over 5 years is better than : 61.69 vs. VIVIX (50.79).
JLVRXVIVIXJLVRX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years26 years-
Gain YTD20.45817.922114%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.11B184B3%
Annual Yield % from dividends1.612.3768%
Returns for 1 year26.5525.54104%
Returns for 3 years14.1421.5766%
Returns for 5 years61.6950.79121%
Returns for 10 years48.35110.5044%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXR164.561.13
+0.69%
Extra Space Storage
PALT1.83N/A
N/A
Paltalk
AOMR9.80-0.06
-0.61%
Angel Oak Mortgage REIT
DLO9.89-0.31
-3.04%
DLocal Limited
GYRE13.12-0.72
-5.20%
Gyre Therapeutics